The ongoing value of first few X studies for COVID-19 in the Western Pacific Region

FFX studies for COVID-19

Authors

  • Adrian Marcato The University of Melbourne, Melbourne, Victoria, Australia
  • James E Fielding Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
  • Kristy Crooks Hunter New England Local Health District, Population Health, Wallsend, New South Wales, Australia; Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia
  • Peter D Massey College of Medicine and Dentistry, James Cook University, Cairns, Queensland, Australia; Hunter New England Local Health District, Population Health, Tamworth, New South Wales, Australia
  • Linh-Vi Le World Health Organization Regional Office for the Western Pacific, Manila, Philippines
  • Isabel Bergeri World Health Organization, Geneva, Switzerland
  • Jodie McVernon The University of Melbourne, Melbourne, Victoria, Australia; Peter Doherty Institute for Infection and Immunity at the University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia; Murdoch Children’s Research Institute, Melbourne, Victoria, Australia

DOI:

https://doi.org/10.5365/wpsar.2022.13.1.873

Abstract

First few ‘X’ (FFX) studies for COVID-19 involve data collection from confirmed cases and their close contacts. They remain relevant especially as many remain susceptible to infection, and as they can provide detailed insight into vaccine effectiveness and the epidemiology of variants of concern, helping to inform a proportionate health response.

Downloads

Published

24-03-2022

How to Cite

1.
Marcato A, Fielding JE, Crooks K, Massey PD, Le L-V, Bergeri I, McVernon J. The ongoing value of first few X studies for COVID-19 in the Western Pacific Region: FFX studies for COVID-19. Western Pac Surveill Response J [Internet]. 2022 Mar. 24 [cited 2023 May 30];13(1):3. Available from: https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/873

Issue

Vol. 13 No. 1 (2022): January ‒ March

Section

COVID-19: Perspective

Categories

Most read articles by the same author(s)

1 2 > >>